Naseem Amin's most recent trade in Avadel Pharmaceuticals plc - ADR was a trade of 11,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avadel Pharmaceuticals plc... | Naseem S Amin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2025 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharmaceuticals plc... | Naseem S Amin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2025 | 11,000 | 22,000 (0%) | 0% | 0 | Ordinary Shares | |
| Avadel Pharmaceuticals plc... | Naseem S Amin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2024 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharmaceuticals plc... | Naseem S Amin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2024 | 11,000 | 11,000 (0%) | 0% | 0 | Ordinary Shares | |
| Avadel Pharmaceuticals plc... | Naseem Amin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 49,500 | 49,500 | - | - | Stock Option (Right to Buy) | |
| Bellerophon Therapeutics Inc | Naseem Amin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 47,578 | 291,865 (0%) | 0% | 0 | Common Stock | |
| Bellerophon Therapeutics Inc | Naseem Amin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 84,000 | 244,287 (0%) | 0% | 0 | Common Stock | |
| Bellerophon Therapeutics Inc | Naseem Amin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2020 | 6,509 | 15,138 | - | - | Stock Option (right to buy) |